跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,813 条关于
“intraperitoneal malignant ascites”
全部
8,813
临床试验
7,949
药物
48
机构
5
资讯
811
去年
CHMP Recommends Approval of Lindis Biotech's Korjuny (catumaxomab) for Malignant Ascites
去年
EMA's CHMP Recommends 10 New Medicines, Including Novel Therapies and Biosimilars
去年
Catumaxomab Receives European Marketing Authorization for Malignant Ascites Treatment
9个月前
Pharmanovia Launches First-in-Class Korjuny (Catumaxomab) in Germany for Malignant Ascites Treatment
5个月前
SBP Group's M701 Bispecific Antibody Receives NDA Acceptance for Malignant Ascites Treatment
去年
Pharmanovia In-Licenses Catumaxomab for Malignant Ascites Treatment
去年
Lindis Biotech and Pharmanovia Partner to Relaunch Catumaxomab for Malignant Ascites
去年
EMA Recommends Approvals for Novel Therapies Targeting Cancer, Hemophilia, and Neurological Disorders
3个月前
Saliva-Based Surrogate Marker Predicts Malignant Transformation in Oral Potentially Malignant Disorders
4年前
Sequana Medical Receives FDA IDE Approval to Commence alfapump Pivotal Study for Refractory Ascites
第 1 页，共 82 页
上一页
下一页
